Roles > EC 2.3.3.8 (ATP citrate synthase) inhibitor
Page last updated: 2024-08-05 15:39:18
EC 2.3.3.8 (ATP citrate synthase) inhibitor
An EC 2.3.3.* (acyltransferase converting acyl to alkyl group on transfer) inhibitor that interferes with the action of ATP citrate synthase (EC 2.3.3.8).
ChEBI ID: 149598
Members (2)
| Member | Definition | Class |
|---|
| etc-1002 | An alpha,omega-dicarboxylic acid that is pentadecanedioic acid which is substituted by methyl groups groups at positions 2 and 14, and by a hydroxy group at position 8. It is a drug used for the treatment of high LDL cholesterol, which is sometimes referred to as 'bad cholesterol'. | bempedoic acid |
| medica 16 | An alpha,omega-dicarboxylic acid that is hexadecanedioic acid carrying methyl groups at positions 3 and 14. It is a free fatty acid 1 (FFA1/GPR40) receptor agonist and an ATP citrate lyase inhibitor, and exhibits hypolipidemic and antidiabetogenic properties. | MEDICA 16 |
Research
Studies (209)
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|
| pre-1990 | 7 (3.35) | 18.7374 |
| 1990's | 14 (6.70) | 18.2507 |
| 2000's | 9 (4.31) | 29.6817 |
| 2010's | 34 (16.27) | 24.3611 |
| 2020's | 145 (69.38) | 2.80 |
Study Types
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|
| Trials | 25 (10.78%) | 5.53% |
| Reviews | 76 (32.76%) | 6.00% |
| Case Studies | 2 (0.86%) | 4.05% |
| Observational | 1 (0.43%) | 0.25% |
| Other | 128 (55.17%) | 84.16% |
Protein Targets (6)
Potency Measurements
Inhibition Measurements
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| ATP-citrate synthase | Rattus norvegicus (Norway rat) | Ki | 11.6667 | 3 | 3 |